Andrew Keaveny is a Gastroenterology physician. OpenAlex indexes 213 publications with 4,057 citations (h-index 33).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4500 San Pablo Rd S
Jacksonville, FL 322241865
Telephone
904-953-2000Provider last certified this registry record 28 Aug 2020.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Salix Pharmaceuticals, a division of Bausch Health US, LLCProgram year20231 payment
- Medtronic, Inc.Program year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
42.1%Bile Acid8.6%Ursodiol100%Part D≥35 patientsCorticosteroid8.6%Prednisone100%Part D≥30 patients+ 7 more classes in this area
Cancer & immunology
30%Calcineurin inhibitor27.8%Tacrolimus90%Cyclosporine Modified10%Part D<11 patientsPurine Antimetabolite1.2%Azathioprine100%Part D<11 patients+ 1 more class in this area
Cardiovascular
18.6%Statin5.1%Simvastatin80%Atorvastatin Calcium20%Part D<11 patientsAldosterone antagonist (MRA)4.1%Spironolactone100%Part D≥21 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Liver function and portal‐systemic shunting quantified by the oral cholate challenge test and risk for large oesophageal varices
Alimentary Pharmacology & Therapeutics
2024 - Global disparities in mortality and liver transplantation in hospitalised patients with cirrhosis: a prospective cohort study for the CLEARED Consortium
The Lancet. Gastroenterology & hepatology
2023 - Emricasan to prevent new decompensation in patients with NASH-related decompensated cirrhosis
Journal of Hepatology
2020
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Charles Rice, MD
The Rockefeller University
Kris Kowdley, MD
Washington State University
Eamonn Quigley, MD
Houston Methodist Hospital and Academic Institute
Patrick Kamath, MD
Mayo Clinic
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”